Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_assertion wasGeneratedBy ECO_0000203 NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_assertion wasDerivedFrom befree-20140225 NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_assertion SIO_000772 14968122 NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_assertion evidence source_evidence_literature NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_assertion description "[The most common familial TTR variants were stabilized substantially by flufenamic acid and inhibitor 1, and to a lesser extent by diflunisal, against acid-mediated fibril formation and chaotrope denaturation, suggesting that this chemotherapeutic option is viable for patients with familial transthyretin amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP845164.RAc3cisSXfobSIWi_RnLEcssEesduL-WvVFcb5vik5BHI130_provenance.